NEWPORT BEACH, Calif., July 11, 2018 /PRNewswire/ -- A new company based out of Southern California is setting its sights on addressing our nation's concussion crisis in a major way. Four to five million concussions occur annually and an estimated 5.3 million Americans live with a traumatic brain injury (TBI) related disability. While fixes like better helmets and the ability to detect concussions in the sports sector are helping, Neurologics' innovative technology could be the life-changer.
"The acute symptoms of a concussion may dissipate over time, but we now know that long-term effects can impact learning, memory, and cognitive function even years after the incident," explains Neurologics Co-Founder and Chief Medical Officer Terry Eagan, M.D. "We're talking about incidents like car accidents, childhood falls, blows from sports like football, hockey, or soccer, anything that results from impacts to the head. Sadly, if not treated, the permanent symptoms of concussions can greatly impact a person's everyday life and cause severe emotional issues."
Dr. Eagan and Neurologics Co-Founder Karen Odell-Barber, MS, CISD, want to change that. The innovative company is at the intersection of mainstream neuroscience and software technology. Their model provides custom-designed, non-invasive, drug-free treatment programs for individuals struggling with cognitive deficits related to TBIs such as concussions. Issues with memory, attention and cognitive function are precisely diagnosed and treated.
"Our technology has deep roots of efficacy combined with the newest advances in software to diagnose, remediate and permanently improve brain function," said Odell-Barber. "We've seen substantial and permanent improvements in auditory processing, cognitive efficiency, delay recall and even IQ."
Neurologics begins by combining FDA-approved qEEG technology that measures brain function at the speed of thought, with proprietary software that measures 293 locations in the brain to create a precise diagnosis of brain impairment. These results are compared to multiple data sets for validation, including those compiled and vetted by the National Institutes of Health (NIH) and New York University. This procedure creates unparalleled accuracy that enables the Neurologics team of neurologists, computer engineers and behavior scientists to create a custom-designed, targeted neuroengineering treatment plan.
Termed Neurologics Neuroengineering™, it is a medical process that is very distinct from typical neurofeedback programs. Using evidence-based protocols, it addresses and remediates the root causes of neurological dysfunction rather than just relieving symptoms.
"We get a full picture of what is happening in the brain and see things other programs and brain maps never see," explains Dr. Eagan. "Of course, what they cannot see, they cannot treat. We see more, so we can treat more. That means the client gets more accurate diagnoses, more targeted treatment plans, and more improvement in cognitive function."
Both Dr. Eagan and Odell-Barber are entrepreneurs in the healthcare space and have consulted for a number of organizations. They are in the process of raising seed funding for Neurologics and building out the management team. Other applications of Neurologics are also underway in the areas of peak performance, cognitive decline and dementia, addiction and recovery, ADHD and learning differences, and child development.
"Concussions and TBIs are our focus right now, but this technology and treatment has widespread implications for a number of brain-related injuries," said Odell-Barber. "We're very excited and optimistic about the potential."
Headquartered in Southern California, Neurologics is an innovative and highly effective brain function diagnostic and remediation company backed by FDA-approved techniques and proprietary software. Neurologics Neuroengineering™ is applied using qEEG to build and reinforce neural pathways that improve cognitive performance. Our advanced clinical delivery model incorporates the latest scientific breakthroughs for cutting-edge results. Neurologics understands that individual clients have individual needs and excels in customizing treatment programs to make them impactful, convenient and successful, one client at a time.
MEDIA CONTACT: Kristen Hayes Media & Public Relations, Neurologics (949) 899-3088 [email protected]